CD8A and neoplasm: Next, we tested our signatures on single-cell sequencing data from tumor-infiltrated lymphocytes (B-cell, Macrophages, CD8+ T cells, and NK cells) in melanoma patients (GSE72056) (10) and observed higher scores for the cognate cell types (Supplementary Figure 1C).